Diagnosis of bacterial respiratory tract infections remains a challenge today, especially within the primary care setting. There is an unmet need to quickly differentiate bacterial from viral respiratory tract infections (e.g. the flu). 40% of antibiotics prescribed are unnecessary, leading to side effects, delayed adequate treatment of the patient and the emergence of resistant bacteria.
Levels Diagnostics is using activated immune cells as biomarkers to allow for an accurate diagnosis of a bacterial infection in patients. The products developed are a FACS immunoassay (to be used in the hospital setting), followed by the development of a rapid diagnostic tool (to be used at the primary care setting). The RDT will provide accurate results within minutes and is portable.